Guidant, J&J Agree To Arbitrate Suits, Exchange Licenses And Technology

Guidant will evaluate in preclinical studies electronic field stimulation (EFS) technology gained through an agreement with Johnson & Johnson before deciding whether to incorporate it into its biventricular pacing device to treat congestive heart failure, the firm says.